What topics does this cannabis study cover?

This study covers research on: THC.

Where was this research published?

Published in Journal of analytical toxicology on June 27, 2026.

THC emerges as major factor in Connecticut traffic fatalities

Q: What did this research study find?

This comprehensive analysis examined **1,816 fatal motor vehicle incidents** in Connecticut between 2020 and 2024, finding that **72% tested positive for at least one drug or alcohol**. Among drivers specifically, the positivity rate was even higher at **75%**, while passengers and pedestrians showe

Drug Detection in Traffic-Related Fatalities in Connecticut (2020-2024).

Journal of analytical toxicology • June 27, 2026 • Moderately Relevant

🤖

AI Summary

This comprehensive analysis examined 1,816 fatal motor vehicle incidents in Connecticut between 2020 and 2024, finding that 72% tested positive for at least one drug or alcohol. Among drivers specifically, the positivity rate was even higher at 75%, while passengers and pedestrians showed rates of 66% and 67% respectively. The most commonly detected substances across all fatality categories were ethanol, delta-9 tetrahydrocannabinol (THC), and fentanyl, with THC consistently ranking as one of the top three drugs involved in traffic deaths.

The data reveals that substance impairment is a pervasive factor in traffic fatalities, affecting not just drivers but also passengers and pedestrians. The prominent presence of THC alongside ethanol and fentanyl highlights the complex challenge of polysubstance use on roadways. This is particularly significant given the legal landscape surrounding cannabis, as THC's role in traffic fatalities suggests that cannabis legalization may require accompanying public health strategies around impaired driving prevention and awareness.

These findings underscore the critical need for targeted prevention strategies, improved toxicology testing protocols, and evidence-based public safety interventions. The data supports continued investment in impaired driving education, roadside testing capabilities, and research into the relationship between cannabis use and driving impairment. For cannabis users, this serves as an important reminder that THC impairs driving ability and contributes meaningfully to traffic fatalities.

📄 Original Abstract

Motor vehicle fatalities continue to be a leading cause of preventable death in the United States. Beginning in 2019, there was a steady uptick in traffic fatalities nationally, which peaked in 2021. The state of Connecticut has experienced similar trends with increases in traffic fatalities over the last several years. The focus of this review was to evaluate drug positivity in traffic-related fatalities that occurred in Connecticut between January 1, 2020 and December 31, 2024. Cases related to traffic fatalities were identified by the state's Office of the Chief Medical Examiner. Deaths of drivers, passengers, and pedestrians were used for the data set. A total of 1,816 fatal motor vehicle incidents were reviewed. Of these, 312 cases lacked toxicology results, and five cases had testing canceled; both were excluded from substance-related analyses. Among the remaining 1,499 cases with available toxicological data, 1,084 (72%) had at least one positive toxicology finding. Drug positivity was identified in 75% (713 of 948) of driver fatalities, 66% (125 of 188) of passenger fatalities, and 67% (221 of 327) of pedestrian fatalities. The most frequently encountered drugs across all three classes of decedents were ethanol, delta-9 tetrahydrocannabinol, and fentanyl. These findings underscore the pervasive role of drugs and alcohol across all categories of traffic-related deaths and highlight the ongoing need for preventive strategies, toxicology testing, and targeted public safety interventions.